Gene expression of the phosphodiesterases 3A and 5A in human corpus cavernosum penis

被引:30
作者
Küthe, A
Mägert, HJ
Ückert, S
Forssmann, WG
Stief, CG
Jonas, U
机构
[1] Hannover Med Sch, Dept Urol, D-30625 Hannover, Germany
[2] Lower Saxony Inst Peptide Res, Hannover, Germany
关键词
phosphodiesterases; human corpus cavernosum; erectile dysfunction; gene expression;
D O I
10.1159/000020262
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: The following study was performed to evaluate the importance of phosphodiesterases 3A (PDE3A) and 5A (PDE5A) for the regulation of penile smooth muscle tone. Furthermore, indications of side effects of specific inhibitors in certain tissues as well as of a possible relation between the level of PDE3A and PDE5A gene expression and erectile dysfunction should have been deduced from the results obtained. Methods: Total ribonucleic acid was isolated from different human tissues (urogenital tract, gastrointestinal tract, cardiovascular system and central nervous system) and subjected to RT-PCR analysis and Northern blotting using primers and probes specific for PDE3A and PDE5A. Results: As shown by RT-PCR and Northern blotting, PDE3A and PDE5A mRNAs exhibit a distinct distribution throughout the tissues examined but were 2-fold higher in cavernous tissue than in all other tissues investigated. However, there were no significant differences in the levels of gene expression between the two subgroups of patients. Conclusions: Very high expression levels of PDE3A and PDE5A in human cavernous tissue underscore the physiological importance of these enzymes for the regulation of penile erection, emphasizing their therapeutical and pharmacological relevance. The distribution pattern of the mRNA for the isoenzymes PDE3A and PDE5A may explain the pharmacological effects as well as the side effects of milrinone and sidenafil. copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:108 / 114
页数:7
相关论文
共 27 条
[1]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155
[2]  
BENTLEY J K, 1992, Current Opinion in Cell Biology, V4, P233
[3]   Sildenafil, a novel effective oral therapy for male erectile dysfunction [J].
Boolell, M ;
GepiAttee, S ;
Gingell, JC ;
Allen, MJ .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (02) :257-261
[4]  
Boolell M, 1996, Int J Impot Res, V8, P47
[5]   9-benzyladenines: Potent and selective cAMP phosphodiesterase inhibitors [J].
Bourguignon, JJ ;
Desaubry, L ;
Raboisson, P ;
Wermuth, CG ;
Lugnier, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (12) :1768-1770
[6]  
Burns F, 1996, Adv Pharmacol, V36, P29, DOI 10.1016/S1054-3589(08)60575-X
[7]   Human platelet cGI-PDE: Expression in yeast and localization of the catalytic domain by deletion mutagenesis [J].
Cheung, PP ;
Xu, H ;
McLaughlin, MM ;
Ghazaleh, FA ;
Livi, GP ;
Colman, RW .
BLOOD, 1996, 88 (04) :1321-1329
[8]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[9]   Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney [J].
Dousa, TP .
KIDNEY INTERNATIONAL, 1999, 55 (01) :29-62
[10]   Oral sildenafil in the treatment of erectile dysfunction [J].
Goldstein, I ;
Lue, TF ;
Padma-Nathan, H ;
Rosen, RC ;
Steers, WD ;
Wicker, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1397-1404